IL77051A - Crystalline form of the monoethanolamine salt of n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide and pharmaceutical compositions containing it - Google Patents

Crystalline form of the monoethanolamine salt of n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide and pharmaceutical compositions containing it

Info

Publication number
IL77051A
IL77051A IL77051A IL7705185A IL77051A IL 77051 A IL77051 A IL 77051A IL 77051 A IL77051 A IL 77051A IL 7705185 A IL7705185 A IL 7705185A IL 77051 A IL77051 A IL 77051A
Authority
IL
Israel
Prior art keywords
crystalline form
benzothiazine
carboxamide
pyridyl
hydroxy
Prior art date
Application number
IL77051A
Other languages
English (en)
Other versions
IL77051A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL77051A0 publication Critical patent/IL77051A0/xx
Publication of IL77051A publication Critical patent/IL77051A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16L—PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL
    • F16L57/00—Protection of pipes or objects of similar shape against external or internal damage or wear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
IL77051A 1984-11-16 1985-11-14 Crystalline form of the monoethanolamine salt of n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide and pharmaceutical compositions containing it IL77051A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/672,028 US4582831A (en) 1984-11-16 1984-11-16 Anti-inflammatory polymorphic monoethanolamine salt of N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide compound, composition, and method of use therefor

Publications (2)

Publication Number Publication Date
IL77051A0 IL77051A0 (en) 1986-04-29
IL77051A true IL77051A (en) 1989-03-31

Family

ID=24696846

Family Applications (1)

Application Number Title Priority Date Filing Date
IL77051A IL77051A (en) 1984-11-16 1985-11-14 Crystalline form of the monoethanolamine salt of n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide and pharmaceutical compositions containing it

Country Status (28)

Country Link
US (1) US4582831A (xx)
EP (1) EP0182572B1 (xx)
JP (1) JPS61122284A (xx)
KR (1) KR870000291B1 (xx)
CN (1) CN1004001B (xx)
AT (1) ATE50257T1 (xx)
AU (1) AU556378B2 (xx)
CA (1) CA1209572A (xx)
DD (1) DD242405A5 (xx)
DE (1) DE3575925D1 (xx)
DK (1) DK171726B1 (xx)
EG (1) EG17621A (xx)
ES (1) ES8701712A1 (xx)
FI (1) FI82045C (xx)
GR (1) GR852772B (xx)
HU (1) HU197899B (xx)
IE (1) IE58288B1 (xx)
IL (1) IL77051A (xx)
IN (1) IN164207B (xx)
MY (1) MY101984A (xx)
NO (1) NO854574L (xx)
NZ (1) NZ214201A (xx)
PH (1) PH21322A (xx)
PL (1) PL149466B1 (xx)
PT (1) PT81490B (xx)
SU (1) SU1491339A3 (xx)
YU (1) YU44019B (xx)
ZA (1) ZA858773B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436241A (en) * 1994-01-14 1995-07-25 Bristol-Myers Squibb Company Topical anti-inflammatory compositions containing piroxicam
US20030068829A1 (en) * 2001-06-25 2003-04-10 Symyx Technologies, Inc. High throughput crystallographic screening of materials
TWI280128B (en) 2002-05-22 2007-05-01 Smithkline Beecham Corp 3'-[(2Z)-[1-(3,4- dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
ECSP077628A (es) * 2007-05-03 2008-12-30 Smithkline Beechman Corp Nueva composición farmacéutica
WO2010138656A1 (en) 2009-05-29 2010-12-02 Glaxosmithkline Llc Methods of administration of thrombopoietin agonist compounds
CN103626777B (zh) * 2009-07-29 2015-10-21 内尔维阿诺医学科学有限公司 Plk抑制剂的盐类
GB0914287D0 (en) * 2009-08-14 2009-09-30 Pci Biotech As Compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
IN160683B (xx) * 1981-06-01 1987-07-25 Pfizer
US4434164A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Crystalline benzothiazine dioxide salts
RO88420A (ro) * 1983-04-25 1986-01-30 Pfizer Inc,Us Procedeu pentru prepararea unor saruri bazice de piroxican depuse pe suporturi farmaceutice

Also Published As

Publication number Publication date
GR852772B (xx) 1986-03-14
KR870000291B1 (ko) 1987-02-25
MY101984A (en) 1992-02-29
JPH0425957B2 (xx) 1992-05-06
EG17621A (en) 1991-08-30
PL149466B1 (en) 1990-02-28
DK171726B1 (da) 1997-04-14
AU4995085A (en) 1986-05-22
FI854512A0 (fi) 1985-11-15
ATE50257T1 (de) 1990-02-15
DD242405A5 (de) 1987-01-28
IE58288B1 (en) 1993-08-25
CN85108245A (zh) 1986-09-03
FI82045B (fi) 1990-09-28
DK527585D0 (da) 1985-11-15
IN164207B (xx) 1989-01-28
PT81490B (pt) 1988-03-03
KR860004038A (ko) 1986-06-16
SU1491339A3 (ru) 1989-06-30
PT81490A (en) 1985-12-01
ZA858773B (en) 1987-06-24
HU197899B (en) 1989-06-28
DK527585A (da) 1986-05-17
IL77051A0 (en) 1986-04-29
EP0182572A1 (en) 1986-05-28
CN1004001B (zh) 1989-04-26
PH21322A (en) 1987-09-28
AU556378B2 (en) 1986-10-30
JPS61122284A (ja) 1986-06-10
NO854574L (no) 1986-05-20
EP0182572B1 (en) 1990-02-07
DE3575925D1 (de) 1990-03-15
ES548878A0 (es) 1986-12-01
ES8701712A1 (es) 1986-12-01
YU178585A (en) 1987-12-31
US4582831A (en) 1986-04-15
YU44019B (en) 1990-02-28
HUT40116A (en) 1986-11-28
IE852852L (en) 1986-05-16
FI854512A (fi) 1986-05-17
NZ214201A (en) 1988-07-28
FI82045C (fi) 1991-01-10
CA1209572A (en) 1986-08-12
PL256259A1 (en) 1986-10-07

Similar Documents

Publication Publication Date Title
AU580355B2 (en) N-((4,6-dimethoxypyrimidin-2-YL)Aminocarbonyl)-3- trifluoromethylpridine-2-sulfonamide or salts thereof, herbicidal composition containing the same, and process for the production of the compound
IL76454A (en) Diarylacetylene derivatives,their preparation and pharmaceutical compositions containing them
PT78703A (en) Process for preparing novel aminomethyl oxooxazolidinyl benzene derivatives useful as antibacterial agents and of pharmaceutical compositions containing the same
PT81007A (en) Process for the preparation of analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives and of pharmaceutical compositions containing the same
PT84737A (en) N-(2(-aminophenyl)-benzamide derivatives process for the preparation thereof and pharmaceutical compositions containing them
EP0328251A3 (en) 2-(2-hydroxy-3-phenoxypropylamino)ethylphenoxyacetamides and processes and intermediates for their preparation
DE3574374D1 (en) Novel n-substituted 3,4-dihydropyrimidine derivatives, processes for preparing them and pharmaceutical compositions
PH25741A (en) Heterocyclic compounds, pharmaceutical composition containing said compound, method of use thereof
PT86635A (pt) Process for the preparation of novel 4-aryl-n-]2-(dialkylamino and heterocyclicamino)-alkyl"-1-piperazinecarboxamides and of pharmaceutical compositions containing the same
HUT41784A (en) Process for producing 1,8-naphtiridine derivatives and pharmaceutical compositions containing them as active agents
IL77051A (en) Crystalline form of the monoethanolamine salt of n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide and pharmaceutical compositions containing it
DE3868013D1 (de) Thiazolderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
HU895241D0 (en) Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient
GB2146982B (en) New 1,3,4-thiadiazole derivatives process for the production thereof and pharmaceutical compositions having antiulcer activity containing the same
HUT39439A (en) Process for producing new thiazolidinedione derivatives and pharmaceutical compositions containing them as active agents
HUT45007A (en) Pesticide compositions containing n-(/2-cyano-2-oximino/-acetyl)-aminonitril derivatives as active components and process for producing the active components
HUT39415A (en) Process for producing new n-/2-hydroxy-alkyi/-amino-acids and derivatives and pharmaceutical compositions containing them as active agents
AU6740187A (en) Heterocyclic compounds, methods for the manufacture of the same and pharmaceutical compositions containing the same
ZA80619B (en) New laevorotatory basic derivative of 9,10-ethanoanthracene,process for the manufacture thereof,pharmaceutical compositions containing this compound and their use

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
EXP Patent expired